Novartis AG — Director's Dealing 2017

Dec 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Intellia Therapeutics, Inc. (NTLA)
CIK: 0001652130
Period of Report: 2017-12-12

Reporting Person: Novartis Institutes for BioMedical Research, Inc. (10% Owner)
Reporting Person: NOVARTIS AG (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-12	Common Stock	S	1523000	$18.30	Disposed	4129903	Direct

Footnotes

F1: The price reported in Column 4 is exclusive of any fees, commissions or other expenses.

F2: The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG.